Leader in #RNAiTherapeutics. Pioneer of this innovative approach to silencing the genes that cause disease. Community guidelines: bit.ly/2FcRhJy.
Cambridge, MA
- Tweets 4,098
- Following 617
- Followers 17,481
- Likes 1,344
The future of cardiology needs more women at the forefront.
Through our work with @WomenAs1, we’re helping expand opportunities for mentorship, collaboration and leadership development to support the next generation of women leaders.
2
201
We've reported Q3 2026 financial results and highlights of recent period activity. Join us LIVE TODAY at 8:30 AM ET to hear from our leadership or access the replay later today at: go-alnylam.com/4BDX1n8
Read the Q3 2026 financial results press release: go-alnylam.com/4yJSgFF
5
928
Last week employees at Alnylam showed up in a big way to support the communities where we live and work. Just how big was our annual Community Service Week this year?
🌍 13 Countries
🏢 30+ Organizations supported
💪 750+ Volunteers
⏰ 2,000+ Volunteer hours
At Alnylam, making a positive impact goes beyond the innovative medicines we develop. It’s also about fostering a culture of service and giving back, driven by a shared passion for making a difference.
9
433
Join us for a live webcast this Thursday, October 29th at 8:30 AM ET when we'll share Third Quarter 2026 financial results.
Register, and access the replay later that day: bit.ly/4BBJM6n
#RNAi #RNAitherapeutics #siRNA
3
391
What if you don’t know the question to ask?
Ozzie & Mike took different paths to an ATTR cardiac amyloidosis diagnosis. Now, they’re sharing the key things they’ve learned and the questions they wish they had known to ask sooner.
8
506
There remains an urgent need for scientific progress in #HuntingtonsDisease (HD).
Hear from Toby Ferguson, our Head of Neuroscience, about our commitment to advancing research for people living with HD, and you can watch the replay of our latest #RNAi Roundtable here: go-alnylam.com/4z08RpP
1
7
596
This @AmyloidosisDay, we’re proud to support #BeTheLink, shining a light on caregivers’ vital role.
Art’s wife, Liz encourages him to share what he’s really experiencing with his physician, being the “voice” that helps him advocate for himself.
1
11
487
For Investors and Media
Join us today at 10:00 AM ET for the 10th #RNAi Roundtable webinar featuring a discussion of the latest data from our investigational program in #HuntingtonsDisease (HD).
Click the link to join the live webinar or access the replay approximately three hours after the event: bit.ly/48k3oy8
1
7
632
For #WorldAmyloidosisDay, we’re honoring caregivers.
Caregiving needs can evolve daily and span years, so it’s essential for caregivers to look after their own well-being.
Hear Ester’s' perspective as a former carer & current ATTR amyloidosis patient: bit.ly/4ijDOOJ
1
5
490
For the eighth year in a row, Alnylam has been recognized as a Science Top Employer!
It's a reflection of our incredible people, our culture and our commitment to bold science. As we continue to expand the possibilities of RNAi, one thing is clear: we're just getting started.
go-alnylam.com/4eJcHva
#ChallengeAccepted
1
5
436
We’re presenting new data on our investigational #RNAi therapeutic in #HuntingtonsDisease (HD) at the European Huntington’s Disease Network (EHDN) Clinical Research Congress. #EHDN2026
Read the full press release: go-alnylam.com/4eNHffj
ALT A digital graphic from Alnylam titled "Initial Phase 1b Data in Huntington’s Disease," presented at the EHDN Clinical Research Congress. It features a brain icon and colored lines on a dark background.
1
3
31
5,704
For Investors and Media
Join us on 10/26 at 10:00 AM ET for the 10th #RNAi Roundtable focused on our latest advances in #HuntingtonsDisease (HD).
Hear from the Alnylam team and scientific experts as they discuss our Phase 1b data in HD.
Register here:go-alnylam.com/4z08RpP
4
554
We’ll be at the European Huntington’s Disease Network (EHDN) Clinical Research Congress presenting new data on our investigational #RNAi therapeutic in development for #HuntingtonsDisease (HD).
We look forward to connecting with the community and discussing the latest scientific advances in HD.
ALT The image is a promotional graphic for the EHDN Clinical Research Congress 2026 by Alnylam. It includes the event dates, "October 22-24," and the text "See you in Kraków, Poland." The background features a scenic view of Kraków with historic buildings.
1
8
647
When it comes to ATTR-CM, it’s important to catch the signs early. 🚨
Former pro football player Pete Shaw, his wife Kari, and cardiologist Dr. Rajeev Mohan are teaming up to spotlight this heart condition. Watch below to stay ahead of the game.
Learn more about Pete’s experience living with ATTR-CM: bit.ly/4jTQ4HW
3
9
474
Meaningful clinical research is built alongside the communities it aims to serve.
See how community insights guided key aspects of our global TRITON-CM trial in #ATTR-CM, from expanding opportunities for women to making research more representative of real-world populations. bit.ly/4mfqRGW
3
768
Explore the latest clinical data in transthyretin #amyloidosis with cardiomyopathy (#ATTR-CM) presented at #HFSA2026.
Learn more: go-alnylam.com/4yblxZP
2
10
792
Think of your body as an orchestra. DNA or genes are the sheet music and proteins are the musicians. When the instructions contain errors, disease can occur. #RNAinterference (#RNAi) helps regulate gene activity, treating disease.
Sponsored content w/ Vox bit.ly/4syZfPX
11
814
We're proud to welcome Sandy Waite as our Chief Communications Officer and a member of our Executive Leadership Team. Sandy brings more than 25 years of experience leading communications and public affairs across the biopharmaceutical, healthcare and financial services industries. Prior to joining Alnylam, she held senior leadership roles at Johnson & Johnson Innovative Medicine, CVS Health and Aetna. Learn more about Sandy: go-alnylam.com/4hfGQnL
1
3
747
We're heading to the 58th European Society for Paediatric Nephrology Annual Meeting!
Learn more about this conference at: go-alnylam.com/4hVNKP6
#ESPN2026 #nephrology
6
685